A narrative review evaluates preclinical evidence for pairing the anesthetic dexmedetomidine with biomaterial scaffolds to ...
A retrospective single-center study found that adding low-dose dexmedetomidine to ciprofol was associated with fewer ...
Teva's celiac disease drug TEV-408 became the first treatment to protect celiac patients' intestines from gluten damage in a ...
Tech Times on MSN
Teva Pharmaceutical R&D Day 2026: First-in-class drugs for Tourette syndrome, celiac disease, and IBD scarring
Teva Pharmaceutical's inaugural R&D Day unveiled three first-in-class drugs targeting Tourette syndrome in children, celiac disease, and IBD -- conditions no approved therapy fully addresses -- ...
ASAM has issued its first national clinical considerations on recognizing and treating medetomidine use and withdrawal in the ...
Medetomidine is complicating withdrawal from illicit drugs, leaving people struggling to find treatment that can help them ...
Detailed price information for Bioxcel Therapeutics Inc (BTAI-Q) from The Globe and Mail including charting and trades.
Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results